Novavax, Inc. (NVAX)
NASDAQ·Healthcare·Biotechnology
$7.62
+2.84%
Mkt Cap $1.22B
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
Implied Upside
+136.2%
Consensus $18.00 vs current $7.62
NASDAQ·Healthcare·Biotechnology
$7.62
+2.84%
Mkt Cap $1.22B
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
+136.2%
Consensus $18.00 vs current $7.62